---
title: 'Clinical impact of inappropriate DOAC dosing in atrial fibrillation: Insights
  from a real-world registry'
date: '2025-01-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39867851/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250127170523&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'BACKGROUND: A significant number of patients with atrial fibrillation
  (AF) on direct oral anticoagulants (DOACs) receives off-label or inappropriate doses.
  This study examines the prevalence, dosages, and clinical outcomes in AF-patients
  on DOAC therapy admitted to an emergency department ...'
disable_comments: true
---
BACKGROUND: A significant number of patients with atrial fibrillation (AF) on direct oral anticoagulants (DOACs) receives off-label or inappropriate doses. This study examines the prevalence, dosages, and clinical outcomes in AF-patients on DOAC therapy admitted to an emergency department ...